29.03.2020 21:09
(Act. 29.03.2020 21:13)
–
–
A cancer drug is also “very promising”.
© APA – EPA – Steffen Schmidt
–
–
–
Pharmaceutical giant Novartis has high hopes for the malaria drug.
The Swiss pharmaceutical company Novartis has high hopes in the malaria drug hydroxychloroquine in the search for a cure for the coronavirus. “Preclinical studies with animals and initial data from clinical studies show that it kills the coronavirus,” Novartis boss Vasant Narasimhan told the “SonntagsZeitung”.
–
Approval by express procedure
Patients are currently being sought for clinical trials in Europe and the USA, and rapid approval approval is being examined in cooperation with the regulatory authorities in the USA and Switzerland.
–
Cancer drug Jakavi “very promising”
In addition, other drugs that have already been developed would be examined to see whether they could be used against Covid-19. The cancer drug Jakavi is “very promising,” said the Novartis boss.
–
In addition, the multiple sclerosis drug Gilenya and Ilaris, a drug for febrile syndromes, would be examined for possible use.
–
– .
